ImmunityBio: Q1 Earnings Snapshot
News > National News
Audio By Carbonatix
6:32 PM on Friday, May 12, 2023
The Associated Press
SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Thursday reported a loss of $116.3 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 27 cents.
The immunotherapy company posted revenue of $360,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IBRX at https://www.zacks.com/ap/IBRX